BC Platforms and NTT Life Science Corporation have joined forces to accelerate data-driven medicine through the Japan Precision Medicine PlatformTM , aiming to integrate and analyze Japanese healthcare data for personalized therapies. This collaboration seeks to address Japan’s healthcare challenges while fostering innovation in precision medicine through the utilization of real-world data.
We are delighted that NTT Life Science will exclusively represent our technology in Japan. This powerful strategic partnership with NTT Group is a core element of our mission to be a leading real-world data, technology, and services provider. By collaborating with one of the world’s largest technology companies, we boost our ability to scale, and maximize, the value of our capabilities, as we build the world’s largest health data network.
said BCP’s Chairman of the Board, Laurent Samama.
Access to their full press release here